| VARSIMLA GLAXOSMITHKLINE INTELLECTUAL PROPERTY LIMITED
1349450 30 May 2007 | on 27 Jan 2016 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use in the treatment of alimentary tract disorders, allergic conditions, autoimmune diseases, blood disorders, bone diseases and injuries, bone marrow and stem cell transplantation, cardiovascular diseases, central nervous system disorders namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, depression and anxiety and their related disorders namely schizophrenia and psychoses, connective tissue disorders, ear, nose and throat conditions, endocrinology disorders, gastrointestinal diseases, genetic diseases, immunologic conditions namely mastocytosis, hives, angioedema, anaphylactic reactions and immunologic deficiency syndromes, infectious diseases namely prostatitis, nephritis, cystitis, vaginitis, sexually transmitted diseases, renal disease, joint diseases, kidney diseases, liver diseases, metabolic diseases, neurological disorders namely Parkinson's Disease, Alzheimers disease, dementia, epilepsy, Huntington's disease and muscular dystrophy, nutritional disorders namely for the treatment of obesity or to aid in weight loss or weight management, oncological conditions, ophthalmologic diseases, organ transplantation, pancreatic disorders, respiratory diseases, dermatologic disorders namely dermatitis, skin and skin structure diseases, infections, and injuries, psoriasis, eczema, and sexually transmitted diseases, thrombotic diseases, vascular diseases, tendon and muscular damage, back and joint dysfunction, skin wounds, soft tissue damage and disorders, and inflammation and inflammatory related diseases and disorders namely arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, COPD, asthma, atherosclerosis, vasculitis, synovitis, psoriasis, eczema, scleroderma, and other inflammatory-related skin disorders. | |